MiNK Therapeutics, Inc.INKTNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank67
3Y CAGR-10.0%
5Y CAGR+35.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-10.0%/yr
Annual compound
5Y CAGR
+35.5%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
4.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $5.63M | +37.3% |
| 2024 | $4.10M | -44.8% |
| 2023 | $7.43M | -3.6% |
| 2022 | $7.71M | +69.1% |
| 2021 | $4.56M | +270.1% |
| 2020 | $1.23M | -67.8% |
| 2019 | $3.83M | - |